Abstract
Nanobiotechnology has been demonstrated to be an efficient tool for targeted therapy as well as diagnosis, with particular emphasis on brain tumor and neurodegenerative diseases. On this regard, the aim of this chapter is focused on engineered nanoparticles targeted to the brain, so that they have the ability to overcome the blood–brain barrier (BBB) and enter the brain tissue. Firstly, it highlighted the difficulty of physically active molecules and colloidal carriers to overcome BBB, which is an impediment for the treatment of several brain diseases; then, the use of nanoparticles as advantageous carriers to cross the BBB and achieve brain, and their functionalization strategies are described; and finally the delivery of nanoparticles to the target moiety, as diagnostics or therapeutics. Therefore, this chapter is focused on how the nanoparticle surface may be functionalized for drug delivery and diagnostics. Furthermore, it is also mentioned that some BBB targets were already used as transport mediators to central nervous system by functionalization on nanoparticles. It summarizes the nanoparticles potential in therapeutics and molecular targeting to BBB, and also an approach of the nanoparticle-mediated drug transport across the BBB, where nanoparticles take advantage of physiological receptor-mediated transport processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
N.J. Abbott, Blood–brain barrier structure and function and the challenges for CNS drug delivery. J. Inherit. Metab. Dis. 36, 1–13 (2013)
N.J. Abbott, A.A. Patabendige, D.E. Dolman, S.R. Yusof, D.J. Begley, Structure and function of the blood–brain barrier. Neurobiol. Dis. 37(1), 13–25 (2010)
M.I. Alam, S. Beg, A. Samad, S. Baboota, K. Kohli, J. Ali, A. Ahuja, M. Akbar, Strategy for effective brain drug delivery. Eur. J. Pharm. Sci. 40(5), 385–403 (2010)
D.D. Allen, P.R. Lockman, K.E. Roder, L.P. Dwoskin, P.A. Crooks, Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood–brain barrier choline transporter. J. Pharmacol. Exp. Ther. 304(3), 1268–1274 (2003)
L. Araujo, R. Löbenberg, J. Kreuter, Influence of the surfactant concentration on the body distribution of nanoparticles. J. Drug Target. 6(5), 373–385 (1999)
A. Armulik, G. Genové, M. Mäe, M.H. Nisancioglu, E. Wallgard, C. Niaudet, L. He, J. Norlin, P. Lindblom, K. Strittmatter, Pericytes regulate the blood–brain barrier. Nature 468(7323), 557–561 (2010)
D.J. Begley, ABC transporters and the blood–brain barrier. Curr. Pharm. Des. 10(12), 1295–1312 (2004)
S. Bhaskar, F. Tian, T. Stoeger, W. Kreyling, J.M. de la Fuente, V. Grazu, P. Borm, G. Estrada, V. Ntziachristos, D. Razansky, Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood–brain barrier: perspectives on tracking and neuroimaging. Part. Fibre Toxicol. 7, 3 (2010)
A. Bolhassani, Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim. Biophys. Acta 1816(2), 232–246 (2011)
I. Brigger, J. Morizet, G. Aubert, H. Chacun, M.-J. Terrier-Lacombe, P. Couvreur, Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J. Pharmacol. Exp. Ther. 303(3), 928–936 (2002)
F.L. Cardoso, D. Brites, M.A. Brito, Looking at the blood–brain barrier: molecular anatomy and possible investigation approaches. Brain Res. Rev. 64(2), 328–363 (2010)
Y. Chen, L. Liu, Modern methods for delivery of drugs across the blood–brain barrier. Adv. Drug Deliv. Rev. 64(7), 640–665 (2012)
Y. Chen, G. Dalwadi, H.A. Benson, Drug delivery across the blood–brain barrier. Curr. Drug Deliv. 1(4), 361–376 (2004)
Y.K. Choi, K.-W. Kim, Blood-neural barrier: its diversity and coordinated cell-to-cell communication. Genesis 10, 11 (2008)
P. Couvreur, B. Kante, L. Grislain, M. Roland, P. Speiser, Toxicity of polyalkylcyanoacrylate nanoparticles II: doxorubicin-loaded nanoparticles. J. Pharm. Sci. 71, 790–792 (1982)
S. Dauchy, F. Dutheil, R.J. Weaver, F. Chassoux, C. Daumas-Duport, P.O. Couraud, J.M. Scherrmann, I. De Waziers, X. Declèves, ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier. J. Neurochem. 107(6), 1518–1528 (2008)
A. De Boer, P. Gaillard, Drug targeting to the brain. Annu. Rev. Pharmacol. Toxicol. 47, 323–355 (2007)
M. Dean, Y. Hamon, G. Chimini, The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42(7), 1007–1017 (2001)
B. Dehouck, L. Fenart, M.-P. Dehouck, A. Pierce, G. Torpier, R. Cecchelli, A new function for the LDL receptor: transcytosis of LDL across the blood–brain barrier. J. Cell Biol. 138(4), 877–889 (1997)
K.R. Duffy, W.M. Pardridge, Blood–brain barrier transcytosis of insulin in developing rabbits. Brain Res. 420, 32–38 (1987)
K.R. Duffy, W.M. Pardridge, R.G. Rosenfeld, Human blood–brain barrier insulin-like growth factor receptor. Metabolism 37(2), 136–140 (1988)
M. Fisher, Pericyte signaling in the neurovascular unit. Stroke 40(3 Suppl. 1), S13–S15 (2009)
M. Fisher, M. Abramov, A. Van Aerschot, D. Xu, R.L. Juliano, P. Herdewijn, Inhibition of MDR1 expression with altritol-modified siRNAs. Nucleic Acids Res. 35(4), 1064–1074 (2007)
R. Gabathuler, Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases. Neurobiol. Dis. 37(1), 48–57 (2010)
P.J. Gaillard, A. Brink, A.G. de Boer, Diphtheria toxin receptor-targeted brain drug delivery. Int. Congr. Ser. 1277, 185–198 (2005)
P.J. Gaillard, C.C. Appeldoorn, J. Rip, R. Dorland, S.M. van der Pol, G. Kooij, H.E. de Vries, A. Reijerkerk, Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J. Control. Release 164(3), 364–369 (2012)
A. Gessner, A. Lieske, B.R. Paulke, R.H. Muller, Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur. J. Pharm. Biopharm. 54(2), 165–170 (2002)
S. Gill, R. Löbenberg, T. Ku, S. Azarmi, W. Roa, E.J. Prenner, Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery – a review. J. Biomed. Nanotechnol. 3(2), 107–119 (2007)
J.L. Gilmore, X. Yi, L. Quan, A.V. Kabanov, Novel nanomaterials for clinical neuroscience. J. Neuroimmune Pharmacol. 3(2), 83–94 (2008)
T.M. Goppert, R.H. Muller, Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J. Drug Target. 13(3), 179–187 (2005)
A. Gulyaev, S. Gelperina, I. Skidan, A. Antropov, G. Kivman, J. Kreuter, Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm. Res. 16, 1564–1569 (1999)
A. Hartz, B. Bauer, Regulation of ABC transporters at the blood–brain barrier: new targets for CNS therapy. Mol. Interv. 10(5), 293 (2010)
F. Hervé, N. Ghinea, J.-M. Scherrmann, CNS delivery via adsorptive transcytosis. AAPS J. 10(3), 455–472 (2008)
H. Hillaireau, P. Couvreur, Nanocarriers’ entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 66(17), 2873–2896 (2009)
G.H. Huynh, D.F. Deen, F.C. Szoka Jr., Barriers to carrier mediated drug and gene delivery to brain tumors. J. Control. Release 110(2), 236–259 (2006)
R.K. Jain, Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control. Release 74, 7–25 (2001)
K. Jain, Role of nanotechnology in developing new therapies for diseases of the nervous system. Nanomedicine 1(1), 9–12 (2006)
K.K. Jain, The Handbook of Nanomedicine (Springer, Dordrecht, 2012)
S.W. Jones, R. Christison, K. Bundell, C.J. Voyce, S.M. Brockbank, P. Newham, M.A. Lindsay, Characterisation of cell-penetrating peptide-mediated peptide delivery. Br. J. Pharmacol. 145(8), 1093–1102 (2005)
L. Juillerat-Jeanneret, The targeted delivery of cancer drugs across the blood–brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov. Today 13(23–24), 1099–1106 (2008)
I.P. Kaur, R. Bhandari, S. Bhandari, V. Kakkar, Potential of solid lipid nanoparticles in brain targeting. J. Control. Release 127(2), 97–109 (2008)
M. Lindgren, U. Langel, Classes and prediction of cell-penetrating peptides. Methods Mol. Biol. 683, 3–19 (2011)
C.A. Lipinski, Lead-and drug-like compounds: the rule-of-five revolution. Drug. Discov. Today Technol. 1(4), 337–341 (2004)
C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23(1), 3–25 (1997)
L. Liu, K. Guo, J. Lu, S.S. Venkatraman, D. Luo, K.C. Ng, E.-A. Ling, S. Moochhala, Y.-Y. Yang, Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG–TAT for drug delivery across the blood–brain barrier. Biomaterials 29(10), 1509–1517 (2008)
P. Lockman, R. Mumper, M. Khan, D. Allen, Nanoparticle technology for drug delivery across the blood–brain barrier. Drug Dev. Ind. Pharm. 28(1), 1–13 (2002)
P.R. Lockman, J.M. Koziara, R.J. Mumper, D.D. Allen, Nanoparticle surface charges alter blood–brain barrier integrity and permeability. J. Drug Target. 12(9–10), 635–641 (2004)
H. Maeda, J. Fang, T. Inutsuka, Y. Kitamoto, Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int. Immunopharmacol. 3(3), 319–328 (2003)
S. Majumdar, T.J. Siahaan, Peptide-mediated targeted drug delivery. Med. Res. Rev. 32(3), 637–658 (2012)
Y.M. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387–6392 (1986)
K. Michaelis, M.M. Hoffmann, S. Dreis, E. Herbert, R.N. Alyautdin, M. Michaelis, J. Kreuter, K. Langer, Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J. Pharmacol. Exp. Ther. 317(3), 1246–1253 (2006)
T. Moos, E.H. Morgan, Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 20(1), 77–95 (2000)
S.K. Murthy, Nanoparticles in modern medicine: state of the art and future challenges. Int. J. Nanomedicine 2(2), 129–141 (2007)
K. Nagpal, S.K. Singh, D.N. Mishra, Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB. Expert Opin. Drug Deliv. 10, 927–955 (2013)
A. Nunes, K.T. Al-Jamal, K. Kostarelos, Therapeutics, imaging and toxicity of nanomaterials in the central nervous system. J. Control. Release 161(2), 290–306 (2012)
W.M. Pardridge, Drug and gene delivery to the brain: the vascular route. Neuron 36(4), 555–558 (2002)
W.M. Pardridge, Blood–brain barrier drug targeting: the future of brain drug development. Mol. Interv. 3(2), 90 (2003)
W.M. Pardridge, The blood–brain barrier: bottleneck in brain drug development. NeuroRx 2(1), 3–14 (2005)
W.M. Pardridge, Blood–brain barrier delivery. Drug Discov. Today 12(1–2), 54–61 (2007)
W.M. Pardridge, J. Eisenberg, J. Yang, Human blood–brain barrier transferrin receptor. Metabolism 36(9), 892–895 (1987)
W.M. Pardridge, J.L. Buciak, P.M. Friden, Selective transport of an anti-transferrin receptor antibody through the blood–brain barrier in vivo. J. Pharmacol. Exp. Ther. 259(1), 66–70 (1991)
M. Ribeiro, M. Castanho, I. Serrano, In vitro blood–brain barrier models-latest advances and therapeutic applications in a chronological perspective. Mini Rev. Med. Chem. 10(3), 263–271 (2010)
A. Saleh, M. Schroeter, C. Jonkmanns, H. Hartung, U. Mödder, S. Jander, In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127, 1670–1677 (2004)
S. Santaguida, D. Janigro, M. Hossain, E. Oby, E. Rapp, L. Cucullo, Side by side comparison between dynamic versus static models of blood? brain barrier in vitro: a permeability study. Brain Res. 1109(1), 1–13 (2006)
H. Santos, L. Bimbo, J. das Neves, B. Sarmento, Nanoparticulate targeted drug delivery using peptides and proteins, in Nanomedicine: Technologies and Applications, ed. by T.J. Webster (Woodhead Publishing Limited, Cambridge, 2012)
K. Tahara, Y. Miyazaki, Y. Kawashima, J. Kreuter, H. Yamamoto, Brain targeting with surface-modified poly(d, l-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration. Eur. J. Pharm. Biopharm. 77(1), 84–88 (2011). doi:10.1016/j.ejpb.2010.11.002
J.E. Vance, H. Hayashi, Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim. Biophys. Acta 1801(8), 806–818 (2010)
J.S. Weinstein, C.G. Varallyay, E. Dosa, S. Gahramanov, B. Hamilton, W.D. Rooney, L.L. Muldoon, E.A. Neuwelt, Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J. Cereb. Blood Flow Metab. 30(1), 15–35 (2010)
N. Weiss, F. Miller, S. Cazaubon, P.-O. Couraud, The blood–brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta 1788(4), 842–857 (2009)
B. Wilson, M.K. Samanta, K. Santhi, K.P. Kumar, N. Paramakrishnan, B. Suresh, Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Eur. J. Pharm. Biopharm. 70(1), 75–84 (2008). doi:10.1016/j.ejpb.2008.03.009
J.L. Winer, P.E. Kim, M. Law, C.Y. Liu, M.L. Apuzzo, Visualizing the future: enhancing neuroimaging with nanotechnology. World Neurosurg. 75(5–6), 626–637 (2011)
S. Wohlfart, S. Gelperina, J. Kreuter, Transport of drugs across the blood–brain barrier by nanoparticles. J. Control. Release 161(2), 264–273 (2012)
H. Xin, L. Chen, J. Gu, X. Ren, Z. Wei, J. Luo, Y. Chen, X. Jiang, X. Sha, X. Fang, Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(varepsilon-caprolactone) nanoparticles: in vitro and in vivo evaluation. Int. J. Pharm. 402(1–2), 238–247 (2010)
Acknowledgment
Maria João Gomes gratefully acknowledges Fundação para a Ciência e a Tecnologia (FCT), Portugal, for financial support (grant SFRH/BD/90404/2012). This work was partially supported by a grant from FCT (PTDC/SAU-FAR/112277/2009).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this entry
Cite this entry
Gomes, M.J., Mendes, B., Martins, S., Sarmento, B. (2016). Nanoparticle Functionalization for Brain Targeting Drug Delivery and Diagnostic. In: Aliofkhazraei, M. (eds) Handbook of Nanoparticles. Springer, Cham. https://doi.org/10.1007/978-3-319-15338-4_42
Download citation
DOI: https://doi.org/10.1007/978-3-319-15338-4_42
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15337-7
Online ISBN: 978-3-319-15338-4
eBook Packages: Chemistry and Materials ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics